Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers
暂无分享,去创建一个
Chi Wang | Jinpeng Liu | B. Hennig | T. Gwag | Xiaofei Zhang | Dong Li | Murong Ma | P. Deng | Jerika Durham | Dong Li
[1] Yuanxiang Jin,et al. Aberrant hepatic lipid metabolism associated with gut microbiota dysbiosis triggers hepatotoxicity of novel PFOS alternatives in adult zebrafish. , 2022, Environment international.
[2] E. Hatano,et al. Propionic Acid, Induced in Gut by an Inulin Diet, Suppresses Inflammation and Ameliorates Liver Ischemia and Reperfusion Injury in Mice , 2022, Frontiers in Immunology.
[3] G. Bothun,et al. Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. , 2022, Toxicology and applied pharmacology.
[4] Yawei Wang,et al. Effect of Enterohepatic Circulation on the Accumulation of Per- and Polyfluoroalkyl Substances: Evidence from Experimental and Computational Studies. , 2022, Environmental science & technology.
[5] Shaoqi Yang,et al. Inulin activates FXR-FGF15 signaling and further increases bile acids excretion in non-alcoholic fatty liver disease mice. , 2022, Biochemical and biophysical research communications.
[6] Yung-Fu Chang,et al. Gut microbiota disturbance exaggerates battery wastewater-induced hepatotoxicity through a gut-liver axis , 2021, Science of The Total Environment.
[7] J. Peters,et al. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice. , 2021, Toxicology.
[8] M. Orešič,et al. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease. , 2021, Journal of hepatology.
[9] C. Fava,et al. Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence , 2021, Frontiers in Endocrinology.
[10] J. Xia,et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights , 2021, Nucleic Acids Res..
[11] Yangyang Zhang,et al. Distribution of perfluorooctane sulfonate in mice and its effect on liver lipidomic. , 2021, Talanta.
[12] P. O’Toole,et al. Dietary Fibre Modulates the Gut Microbiota , 2021, Nutrients.
[13] Wei Wei,et al. Perfluorooctanesulfonic acid (PFOS) thwarts the beneficial effects of calorie restriction and Metformin. , 2021, Toxicological sciences : an official journal of the Society of Toxicology.
[14] H. Moseley,et al. Untargeted Stable Isotope Probing of the Gut Microbiota Metabolome Using 13C-Labeled Dietary Fibers. , 2021, Journal of proteome research.
[15] R. Choi,et al. Ceramides and other sphingolipids as drivers of cardiovascular disease , 2021, Nature Reviews Cardiology.
[16] A. Baccarelli,et al. Hallmarks of environmental insults , 2021, Cell.
[17] F. Foufelle,et al. Roles of Ceramides in Non-Alcoholic Fatty Liver Disease , 2021, Journal of clinical medicine.
[18] B. Hennig,et al. Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice. , 2020, Toxicology and applied pharmacology.
[19] M. Weickert,et al. The Health Benefits of Dietary Fibre , 2020, Nutrients.
[20] Marisa Pfohl,et al. Perfluorooctanesulfonic acid (PFOS) and perfluorohexanesulfonic acid (PFHxS) alter the blood lipidome and the hepatic proteome in a murine model of diet-induced obesity. , 2020, Toxicological sciences : an official journal of the Society of Toxicology.
[21] F. Akhlaghi,et al. Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice. , 2020, Toxicology and applied pharmacology.
[22] M. Bücking,et al. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019. , 2020, Environment international.
[23] Xiaojun Ge,et al. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study , 2020, BMJ Open.
[24] E. Papadopoulou,et al. Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children , 2020, Hepatology.
[25] G. Celano,et al. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk , 2020, Journal of clinical medicine.
[26] M. Longnecker,et al. The concentration of several perfluoroalkyl acids in serum appears to be reduced by dietary fiber , 2020, medRxiv.
[27] S. Kersten,et al. Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells , 2020, Archives of Toxicology.
[28] R. Fry,et al. Gut Microbiome Toxicity: Connecting the Environment and Gut Microbiome-Associated Diseases , 2020, Toxics.
[29] B. Hennig,et al. Healthful nutrition as a prevention and intervention paradigm to decrease the vulnerability to environmental toxicity or stressors and associated inflammatory disease risks. , 2020, Food frontiers.
[30] B. Hennig,et al. Prebiotic inulin consumption reduces dioxin-like PCB 126-mediated hepatotoxicity and gut dysbiosis in hyperlipidemic Ldlr deficient mice. , 2020, Environmental pollution.
[31] K. Kleinman,et al. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial. , 2020, Environment international.
[32] H. Malhi,et al. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview , 2020, Hepatology communications.
[33] J. Peters,et al. Perfluorooctane Sulfonate Alters Gut Microbiota-Host Metabolic Homeostasis in Mice. , 2020, Toxicology.
[34] Hongwen Sun,et al. Distribution of novel and legacy per-/polyfluoroalkyl substances in serum and its associations with two glycemic biomarkers among Chinese adult men and women with normal blood glucose levels. , 2019, Environment international.
[35] F. Javaudin,et al. The effects of inulin on gut microbial composition: a systematic review of evidence from human studies , 2019, European Journal of Clinical Microbiology & Infectious Diseases.
[36] Dean P. Jones,et al. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. , 2019, Environment international.
[37] Jennifer Lu,et al. Improved metagenomic analysis with Kraken 2 , 2019, Genome Biology.
[38] Yuanxiang Jin,et al. Bioaccumulation in the gut and liver causes gut barrier dysfunction and hepatic metabolism disorder in mice after exposure to low doses of OBS. , 2019, Environment international.
[39] B. Stecher,et al. Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family , 2019, Microbiome.
[40] B. Hennig,et al. Hepatic metabolomics reveals that liver injury increases PCB 126-induced oxidative stress and metabolic dysfunction. , 2019, Chemosphere.
[41] G. Shearer,et al. Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation , 2019, Gut.
[42] Heather M. Wallace,et al. Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food , 2018, EFSA journal. European Food Safety Authority.
[43] J. Allen,et al. A Review of the Pathways of Human Exposure to Poly- and Perfluoroalkyl Substances (PFASs) and Present Understanding of Health Effects , 2018, Journal of Exposure Science & Environmental Epidemiology.
[44] K. Lai,et al. Dietary Exposure to the Environmental Chemical, PFOS on the Diversity of Gut Microbiota, Associated With the Development of Metabolic Syndrome , 2018, Front. Microbiol..
[45] Jimmy D Bell,et al. The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease , 2018, Diabetes, obesity & metabolism.
[46] Kassem M. Makki,et al. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. , 2018, Cell host & microbe.
[47] H. Gilbert,et al. Biochemistry of complex glycan depolymerisation by the human gut microbiota , 2018, FEMS microbiology reviews.
[48] S. Summers,et al. Could Ceramides Become the New Cholesterol? , 2018, Cell metabolism.
[49] Curtis Huttenhower,et al. bioBakery: a meta’omic analysis environment , 2017, Bioinform..
[50] Y. Li,et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water , 2017, Occupational and Environmental Medicine.
[51] Diane Quagliani,et al. Closing America’s Fiber Intake Gap , 2017, American journal of lifestyle medicine.
[52] D. Ehresman,et al. Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[53] H. Tilg,et al. Gut microbiome and liver diseases , 2016, Gut.
[54] K. Lai,et al. Fatty liver disease induced by perfluorooctane sulfonate: Novel insight from transcriptome analysis. , 2016, Chemosphere.
[55] M. Blaut,et al. Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high‐fat diet‐induced obesity , 2016, Molecular nutrition & food research.
[56] D. van Sinderen,et al. Bifidobacteria and Their Role as Members of the Human Gut Microbiota , 2016, Front. Microbiol..
[57] Steven Salzberg,et al. Bracken: Estimating species abundance in metagenomics data , 2016, bioRxiv.
[58] W. Elkashef,et al. Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells. , 2016, Canadian journal of physiology and pharmacology.
[59] W. Hinrichs,et al. Inulin, a flexible oligosaccharide. II: Review of its pharmaceutical applications. , 2015, Carbohydrate polymers.
[60] L. S. Haug,et al. Examining confounding by diet in the association between perfluoroalkyl acids and serum cholesterol in pregnancy. , 2015, Environmental research.
[61] S. Summers,et al. Ceramides – Lipotoxic Inducers of Metabolic Disorders , 2015, Trends in Endocrinology & Metabolism.
[62] S. Summers. The ART of Lowering Ceramides. , 2015, Cell metabolism.
[63] J. Forster,et al. Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[64] Yawei Wang,et al. Differential accumulation and elimination behavior of perfluoroalkyl Acid isomers in occupational workers in a manufactory in China. , 2015, Environmental science & technology.
[65] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[66] E. Botchwey,et al. Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD. , 2014, Blood.
[67] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[68] G. Jiang,et al. PFOS induced lipid metabolism disturbances in BALB/c mice through inhibition of low density lipoproteins excretion , 2014, Scientific Reports.
[69] Brett J. Vanderford,et al. Treatment of poly- and perfluoroalkyl substances in U.S. full-scale water treatment systems. , 2014, Water research.
[70] Damià Barceló,et al. Accumulation of perfluoroalkyl substances in human tissues. , 2013, Environment international.
[71] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[72] D. Ehresman,et al. Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys. , 2012, Reproductive toxicology.
[73] J. Giesy,et al. PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport. , 2012, Biochimica et biophysica acta.
[74] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[75] A. Ikari,et al. Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug-metabolizing enzymes in rats fed a high-fat and high-sucrose diet , 2012, Nutrition & Metabolism.
[76] W. Sanderson,et al. Nutrition Can Modulate the Toxicity of Environmental Pollutants: Implications in Risk Assessment and Human Health , 2012, Environmental health perspectives.
[77] G. Leonardi,et al. Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure , 2012, Environmental health perspectives.
[78] J. Butenhoff,et al. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. , 2011, Toxicology.
[79] M. V. van Erk,et al. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[80] C. Huttenhower,et al. Metagenomic biomarker discovery and explanation , 2011, Genome Biology.
[81] J. Depierre,et al. Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice. , 2010, International immunopharmacology.
[82] A. Futerman,et al. Mammalian ceramide synthases , 2010, IUBMB life.
[83] Xianglin Shi,et al. Perfluorooctane Sulfonate (PFOS) Induces Reactive Oxygen Species (ROS) Production in Human Microvascular Endothelial Cells: Role in Endothelial Permeability , 2010, Journal of toxicology and environmental health. Part A.
[84] Efsa Panel on Dietetic Products. Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre , 2010 .
[85] A. Voragen,et al. Pectin, a versatile polysaccharide present in plant cell walls , 2009 .
[86] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[87] Y. Hannun,et al. The sphingolipid salvage pathway in ceramide metabolism and signaling. , 2008, Cellular signalling.
[88] S. Summers,et al. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.
[89] C. McClain,et al. Using Nutrition for Intervention and Prevention against Environmental Chemical Toxicity and Associated Diseases , 2007, Environmental health perspectives.
[90] J. Sugatani,et al. Dietary Inulin Alleviates Hepatic Steatosis and Xenobiotics-Induced Liver Injury in Rats Fed a High-Fat and High-Sucrose Diet: Association with the Suppression of Hepatic Cytochrome P450 and Hepatocyte Nuclear Factor 4α Expression , 2006, Drug Metabolism and Disposition.
[91] R. A. van den Berg,et al. Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.
[92] R. Freedland,et al. Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. , 1990, The Journal of nutrition.
[93] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[94] B. Abbott,et al. Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ( , / , ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate , 2006 .
[95] S. Summers,et al. Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.
[96] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[97] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .